021-51111890
购物车（）
sales@molnova.cn
Alfuzosin
CAS No. 81403-80-7
Alfuzosin ( —— )
产品货号. M33794 CAS No. 81403-80-7
Alfuzosin (SL 77499-10) 是一种口服有效的，具有选择性和竞争性的 α1-肾上腺素受体拮抗剂。Alfuzosin 能放松前列腺和膀胱颈的肌肉，有助于排尿。Alfuzosin 可用于良性前列腺增生 (BPH) 的研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ￥323 | 有现货 |
|
| 25MG | ￥579 | 有现货 |
|
| 50MG | ￥962 | 有现货 |
|
| 100MG | ￥1507 | 有现货 |
|
| 500MG | ￥3794 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Alfuzosin
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Alfuzosin (SL 77499-10) 是一种口服有效的，具有选择性和竞争性的 α1-肾上腺素受体拮抗剂。Alfuzosin 能放松前列腺和膀胱颈的肌肉，有助于排尿。Alfuzosin 可用于良性前列腺增生 (BPH) 的研究。
-
产品描述Alfuzosin (SL 77499-10) is an orally active, selective and competitive α1-adrenoceptor antagonist. Alfuzosin relaxes the muscles of the prostate and bladder neck, aiding in urination. Alfuzosin can be used in study of benign prostatic hyperplasia (BPH).
-
体外实验——
-
体内实验Alfuzosin hydrochloride (10 mg/kg, p.o.; single) potently antagonizes phenylephrine-induced increases in urethral and arterial pressures up to 6 hours post dosing.Animal Model:Male Wistar rats (250-450 g).Dosage:10 mg/kg Administration:Oral administration; single.Result:Increased prostatic concentrations to 4.1-8.6 times higher than plasma concentration.
-
同义词——
-
通路GPCR/G Protein
-
靶点Adrenergic Receptor
-
受体Adrenergic Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number81403-80-7
-
分子量389.45
-
分子式C19H27N5O4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : ≥ 50 mg/mL (128.39 mM )
-
SMILESCOc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C1CCCO1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Martin DJ, et al. Relationship between the effects of alfuzosin on rat urethral and blood pressures and its tissue concentrations. Life Sci. 1998;63(3):169-76. ?
产品手册
关联产品
-
5-Bromoimidazo[1,2-A...
5-Bromoimidazo[1,2-a]pyrazine inhibits phosphodiesterase and beta-adrenergic receptors.5-Bromoimidazo[1,2-a]pyrazine shows antibronchospastic activity in vitro.
-
(S)-(-)-Atenolol
(S)-(-)-Atenolol has beta-adrenergic blocking effects.
-
Rafabegron
Rafabegron (TAK677) is a potent and selective β3 adrenergic receptor agonist for the study of diabetes and obesity.
